Ranking · Summer 2022 · Healthcare · Drug Discovery and Delivery

Quinn

Your biopharma team, from molecule design to portfolio strategy

6.8%

odds of being acquired in the next two years

1.0× the average (6.8%)

#1965 of 4,339 active YC companies · top 46%

Team of 5 · San Francisco, CA, USA

Raises the odds

↑ tag: Enterprise

↑ team of 3–5

↑ based in United States of America

↑ rewrote its description in the last six months

Lowers the odds

↓ industry: Healthcare

↓ tag: Artificial Intelligence

↓ “design” in its one-liner

From the model: how this company's profile compares with companies that were and weren't acquired since 2024. How it works.

Signals brief

ExitOdds reads Quinn's website and YC profile; Contextrie keeps the passages that bear on an acquisition, and every signal quotes its source.

3 free briefs left today

quinnbio.com YC profile

Statistical estimate from public directory data as of 2026-10-07; it can't see revenue, funding or talks. Not investment advice. ExitOdds is independent and not affiliated with Y Combinator.

Built with open source on GitHub